Publication | Closed Access

iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy

NanoparticlesNanomedicineAnti-hepatocellular Carcinoma EfficacyEngineeringTherapeutic NanomaterialsPolymer-drug ConjugateNano-drug DeliveryTumor TargetingBiomedical EngineeringLipid-polymer Hybrid NanoparticlesRadiation OncologyTargeted Co-delivery